Literature DB >> 15906671

A deficient public health system as a contributing cause of Severe Acute Respiratory Syndrome (SARS) epidemic in mainland China.

Liang Qin1, Hueiwang Jeng, Yasuyuki Rakue, Tsutomu Mizota.   

Abstract

SARS (Severe Acute Respiratory Syndrome) is a newly emerging infectious disease which spread over 32 countries and areas, infected more than 8,000 people and causing more than 900 deaths from November 2002 to August 2003. More than 90% of the SARS cases and death were reported from China. Nevertheless, we still know little about this disease, particularly in etiology. SARS, as an emergency of Public Health System (PHS), alarmed health workers throughout the world proving there is still the potential for an epidemic of an emerging infection both in developed and developing areas. Many reports indicated that the insufficiency of the PHS of China was one of the critical factors contributing to the outbreak of SARS. In this study, we attempt to demonstrate some of the categories of PHS that contributed to the SARS epidemic. Two of the categories studied were the living environment and health resources. In the living environment area, the population and population density were examined. Health resources include the medical facilities, health workers, and per capita public health expenditures. An understanding of these areas is important to prevent future epidemic.

Entities:  

Mesh:

Year:  2005        PMID: 15906671

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  The ORF3a protein of SARS-CoV-2 induces apoptosis in cells.

Authors:  Yujie Ren; Ting Shu; Di Wu; Jingfang Mu; Chong Wang; Muhan Huang; Yang Han; Xue-Yi Zhang; Wei Zhou; Yang Qiu; Xi Zhou
Journal:  Cell Mol Immunol       Date:  2020-06-18       Impact factor: 11.530

2.  Health education services utilization and its determinants among migrants: a cross-sectional study in urban-rural fringe areas of Beijing, China.

Authors:  Shuang Shao; Huirong Zhang; Xiaolei Chen; Xiaojingyuan Xu; Yali Zhao; Meirong Wang; Juan Du
Journal:  BMC Fam Pract       Date:  2021-01-16       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.